1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PIK3R3 CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA PABPN1 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA TIMELESS CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA RP11-729L2.2 CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA KDM6B CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA NLGN3 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA KIFC3 CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA NRBF2 CTRPv2 pan-cancer AAC -0.14 8e-06
mRNA NUP62 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA ELF2 CTRPv2 pan-cancer AAC 0.15 8e-06
Download CSV